BraTS-Path Challenge: Assessing Heterogeneous Histopathologic Brain Tumor Sub-regions

Spyridon Bakas,Siddhesh P. Thakur,Shahriar Faghani,Mana Moassefi,Ujjwal Baid,Verena Chung,Sarthak Pati,Shubham Innani,Bhakti Baheti,Jake Albrecht,Alexandros Karargyris,Hasan Kassem,MacLean P. Nasrallah,Jared T. Ahrendsen,Valeria Barresi,Maria A. Gubbiotti,Giselle Y. López,Calixto-Hope G. Lucas,Michael L. Miller,Lee A. D. Cooper,Jason T. Huse,William R. Bell

2024-05-18

Abstract:Glioblastoma is the most common primary adult brain tumor, with a grim prognosis - median survival of 12-18 months following treatment, and 4 months otherwise. Glioblastoma is widely infiltrative in the cerebral hemispheres and well-defined by heterogeneous molecular and micro-environmental histopathologic profiles, which pose a major obstacle in treatment. Correctly diagnosing these tumors and assessing their heterogeneity is crucial for choosing the precise treatment and potentially enhancing patient survival rates. In the gold-standard histopathology-based approach to tumor diagnosis, detecting various morpho-pathological features of distinct histology throughout digitized tissue sections is crucial. Such "features" include the presence of cellular tumor, geographic necrosis, pseudopalisading necrosis, areas abundant in microvascular proliferation, infiltration into the cortex, wide extension in subcortical white matter, leptomeningeal infiltration, regions dense with macrophages, and the presence of perivascular or scattered lymphocytes. With these features in mind and building upon the main aim of the BraTS Cluster of Challenges

Computer Vision and Pattern Recognition

What problem does this paper attempt to address?

The paper aims to address the following issues:

1. **Assessment of Brain Tumor Heterogeneity**: The paper introduces the BraTS-Path challenge, which aims to evaluate the histopathological landscape of gliomas, particularly glioblastoma (GBM), by automatically detecting and quantifying different morphological regions in whole slide images (WSI). These regions include cellular tumor, pseudopalisading necrosis, microvascular proliferation, geographic necrosis, infiltrating cortex, infiltrating white matter, leptomeningeal infiltration, macrophage-rich areas, and the presence of lymphocytes.

2. **Providing Standardized Datasets and Benchmark Environment**: By offering a systematically prepared comprehensive dataset and a benchmarking environment, it enables the development and fair comparison of deep learning models that can identify tumor subregions with specific histopathological features, thereby furthering the understanding of the disease and assisting in consistent diagnosis and grading.

3. **Advancing Automated Classification Algorithms into Clinical Practice**: The models developed through this challenge help bring automated brain tumor classification algorithms closer to clinical practice, ultimately improving the care level for brain tumor patients.

4. **Enhancing Interdisciplinary Collaboration**: By bringing together researchers, neuropathologists, and data scientists from around the world, it promotes knowledge sharing, collaboration, and interdisciplinary research, accelerating the progress of automated glioma histopathological subregion classification and promoting best practices and standards.

In summary, the challenge aims to utilize the largest professionally annotated multi-label histopathological dataset to provide a standardized benchmark environment for the automated classification of glioblastoma, bridging the gap between research and clinical practice.